

Senate
File
2119
-
Enrolled


Senate
File
2119


AN
ACT


RELATING
TO
CONTROLLED
SUBSTANCES,
INCLUDING
AMENDING
THE


CONTROLLED
SUBSTANCE
SCHEDULES,
REMOVING
CERTAIN
REFERENCES


TO
MARIJUANA,
MAKING
PENALTIES
APPLICABLE,
AND
INCLUDING


EFFECTIVE
DATE
PROVISIONS.


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:



Section
1.
Section
124.201A,
Code
2020,
is
amended
by



striking
the
section
and
inserting
in
lieu
thereof
the



following:



124.201A
Cannabis-derived
products
——
rules.



1.
If
a
cannabis-derived
investigational
product
approved



as
a
prescription
drug
medication
by
the
United
States
food





Senate
File
2119,
p.
2


and
drug
administration
is
added
to
the
federal
schedule


of
controlled
substances
by
the
federal
drug
enforcement



administration
and
notice
of
the
addition
is
given
to
the



board,
the
board
shall
similarly
add
the
prescription
drug



medication
in
the
schedule
of
controlled
substances
under
this



chapter.



2.
If
a
cannabis-derived
product
approved
as
a



prescription
drug
medication
by
the
United
States
food
and



drug
administration
is
eliminated
from
or
revised
in
the



federal
schedule
of
controlled
substances
by
the
federal
drug



enforcement
administration
and
notice
of
the
elimination
or



revision
is
given
to
the
board,
the
board
shall
similarly



eliminate
or
revise
the
prescription
drug
medication
in
the



schedule
of
controlled
substances
under
this
chapter.



3.
The
board
shall
adopt
rules
pursuant
to
chapter
17A



to
administer
this
section.
The
board
may
adopt
rules
on
an



emergency
basis
as
provided
in
section
17A.4,
subsection
3,
and



section
17A.5,
subsection
2,
to
administer
this
section,
and



the
rules
shall
be
effective
immediately
upon
filing
unless



a
later
date
is
specified
in
the
rules.
Any
emergency
rules



adopted
in
accordance
with
this
section
shall
also
be
published



as
a
notice
of
intended
action
as
provided
in
section
17A.4,



subsection
1.



4.
Any
cannabis-derived
investigational
product
or



cannabis-derived
product
approved
as
a
prescription
drug



medication
by
the
United
States
food
and
drug
administration



shall
not
be
considered
marijuana
or
cannabimimetic
agents,



both
as
defined
in
section
124.204,
tetrahydrocannabinols



as
used
in
section
124.204,
subsection
4,
paragraph
“u”
,



unnumbered
paragraph
1,
or
hemp
as
defined
in
section
204.2.



Sec.
2.
Section
124.204,
subsection
2,
Code
2020,
is
amended



by
adding
the
following
new
paragraph:



NEW
PARAGRAPH


.
be.
MT-45
(1-cyclohexyl-4-(1,2-



diphenylethyl)piperazine).



Sec.
3.
Section
124.204,
subsection
4,
paragraph
m,
Code



2020,
is
amended
to
read
as
follows:





m.
Marijuana
,
except
as
otherwise
provided
by
rules
of
the





board
for
medicinal
purposes
.



Sec.
4.
Section
124.204,
subsection
4,
paragraph
u,







Senate
File
2119,
p.
3


unnumbered
paragraph
1,
Code
2020,
is
amended
to
read
as



follows:



Tetrahydrocannabinols,
except
as
otherwise
provided





by
rules
of
the
board
for
medicinal
purposes,


meaning



tetrahydrocannabinols
naturally
contained
in
a
plant
of



the
genus
Cannabis
(Cannabis
plant)
as
well
as
synthetic



equivalents
of
the
substances
contained
in
the
Cannabis
plant,



or
in
the
resinous
extractives
of
such
plant,
and
synthetic



substances,
derivatives,
and
their
isomers
with
similar



chemical
structure
and
pharmacological
activity
to
those



substances
contained
in
the
plant,
such
as
the
following:



Sec.
5.
Section
124.204,
subsection
6,
paragraph
i,
Code



2020,
is
amended
by
adding
the
following
new
subparagraphs:



NEW
SUBPARAGRAPH


.
(27)
1-(1,3-benzodioxol-5-yl)-2-



(ethylamino)-pentan-1-one.
Other
names:
N-ethylpentylone
or



ephylone.



NEW
SUBPARAGRAPH


.
(28)
N-Ethylhexedrone,
its
optical,



positional,
and
geometric
isomers,
salts
and
salts
of
isomers



(Other
name:
2-(ethylamino)-1-phenylhexan-1-one).



NEW
SUBPARAGRAPH


.
(29)
alpha-Pyrrolidinohexanophenone,
its



optical,
positional,
and
geometric
isomers,
salts
and
salts
of



isomers
(Other
names:
α
-PHP;
alpha-pyrrolidinohexiophenone;



1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one).



NEW
SUBPARAGRAPH


.
(30)
4-Methyl-alpha-



ethylaminopentiophenone,
its
optical,
positional,
and
geometric



isomers,
salts
and
salts
of
isomers
(Other
names:
4—MEAP;



2-(ethylamino)-1-(4-methylphenyl)pentan-1-one).



NEW
SUBPARAGRAPH
.
(31)
4’-Methyl-alpha-



pyrrolidinohexiophenone,
its
optical,
positional,
and



geometric
isomers,
salts
and
salts
of
isomers
(Other



names:
MPHP;
4’-methyl-alpha-pyrrolidinohexanophenone;



1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one).



NEW
SUBPARAGRAPH


.
(32)
alpha-Pyrrolidinoheptaphenone,



its
optical,
positional,
and
geometic
isomers,



salts
and
salts
of
isomers
(Other
names:
PV8;



1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one).



NEW
SUBPARAGRAPH


.
(33)
4’-Chloro-alpha-



pyrrolidinovalerophenone,
its
optical,
positional,
and



geometric
isomers,
salts
and
salts
of
isomers
(Other
names:













Senate
File
2119,
p.
4


4-chloro-
α
-PVP;
4’-chloro-alpha-pyrrolidinopentiophenone;



1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one).



Sec.
6.
Section
124.204,
subsection
7,
Code
2020,
is
amended



by
striking
the
subsection.



Sec.
7.
Section
124.204,
subsection
9,
Code
2020,
is
amended



by
adding
the
following
new
paragraphs:



NEW
PARAGRAPH


.
af.
N-(1-phenethylpiperidin-4-yl)-N-



phenylcyclopropanecarboxamide,
its
isomers,
esters,
ethers,



salts
and
salts
of
isomers,
esters,
and
ethers.
Other
name:



cyclopropyl
fentanyl.



NEW
PARAGRAPH


.
ag.
N-(1-phenethylpiperidin-4-yl)-N-



phenylpentanamide,
its
isomers,
esters,
ethers,
salts
and
salts



of
isomers,
esters
and
ethers.
Other
name:
valeryl
fentanyl.



NEW
PARAGRAPH


.
ah.
N-(4-fluorophenyl)-N-(1-



phenethylpiperidin-4-yl)butyramide,
its
isomers,
esters,



ethers,
salts
and
salts
of
isomers,
esters,
and
ethers.
Other



name:
para-fluorobutyryl
fentanyl.



NEW
PARAGRAPH


.
ai.
N-(4-methoxyphenyl)-N-



(1-phenethylpiperidin-4-yl)butryamide,
its
isomers,
esters,



ethers,
salts
and
salts
of
isomers,
esters,
and
ethers.
Other



name:
para-methyoxybutyryl
fentanyl.



NEW
PARAGRAPH


.
aj.
N-(4-chlorophenyl)-N-(1-



phenethylpiperidin-4-yl)isobutryramide,
its
isomers,
esters,



ethers,
salts
and
salts
of
isomers,
esters,
and
ethers.
Other



name:
para-chloroisobutyryl
fentanyl.



NEW
PARAGRAPH


.
ak.
N-(1-phenethylpiperidin-4-yl)-



N-phenylisobutyramide,
its
isomers,
esters,
ethers,
salts
and



salts
of
isomers,
esters,
and
ethers.
Other
name:
isobutyryl



fentanyl.



NEW
PARAGRAPH


.
al.
N-(1-phenethylpiperidin-4-yl)-



N-phenylcyclopentanecarboxamide,
its
isomers,
esters,
ethers,



salts
and
salts
of
isomers,
esters,
and
ethers.
Other
name:





cyclopentyl
fentanyl.



NEW
PARAGRAPH


.
am.
N-(2-fluorophenyl)-2-methoxy-N-



(1-phenethylpiperidin-4-yl)acetamide,
its
isomers,
esters,



ethers,
salts
and
salts
of
isomers,
esters,
and
ethers.
Other



name:
ocfentanil.





NEW
PARAGRAPH


.
an.
Fentanyl-related
substances,
their



isomers,
esters,
ethers,
salts
and
salts
of
isomers,
esters













Senate
File
2119,
p.
5


and
ethers.
“Fentanyl-related
substance”
means
any
substance



not
otherwise
listed
under
this
schedule
or
another
schedule,



and
for
which
no
exemption
or
approval
is
in
effect
under



section
505
of
the
federal
Food,
Drug,
and
Cosmetic
Act
that



is
structurally
related
to
fentanyl
by
one
or
more
of
the



following
modifications:



(1)
Replacement
of
the
phenyl
portion
of
the
phenethyl
group



by
any
monocycle,
whether
or
not
further
substituted
in
or
on



the
monocycle.



(2)
Substitution
in
or
on
the
phenethyl
group
with
alkyl,



alkenyl,
alkoxyl,
hydroxyl,
halo,
haloalkyl,
amino,
or
nitro



groups.



(3)
Substitution
in
or
on
the
piperidine
ring
with
alkyl,



alkenyl,
alkoxyl,
ester,
ether,
hydroxyl,
halo,
haloalkyl,



amino,
or
nitro
groups.



(4)
Replacement
of
the
aniline
ring
with
any
aromatic



monocycle
whether
or
not
further
substituted
in
or
on
the



aromatic
monocycle.



(5)
Replacement
of
the
N
-propionyl
group
by
another
acyl



group.



NEW
PARAGRAPH


.
ao.
Naphthalen-1-yl
1-(5-fluoropentyl)-



1
H
-indole-3-carboxylate.
Other
names:
NM2201
or
CBL2201.



NEW
PARAGRAPH


.
ap.
N
-(1-amino-3-methyl-1-oxobutan-



2-yl)-1-(5-fluoropentyl)-1
H
-indazole-3-carboxamide.
Other



name:
5F-AB-PINACA.



NEW
PARAGRAPH


.
aq.
1-(4-cyanobutyl)-
N
-(2-phenylpropan-



2-yl)-1
H
-indazole-3-carboxamide.
Other
names:



4-CN-CUMYL-BUTINACA,
4-cyano-CUMYL-BUTINACA,
4-CN-CUMYL



BINACA,
CUMYL-4CN-BINACA,
or
SGT-78.



NEW
PARAGRAPH


.
ar.
Methyl
2-(1-(cyclohexylmethyl)-1
H
-



indole-3-carboxamido)-3-methylbutanoate.
Other
names:



MMB-CHMICA
or
AMB-CHMICA.





NEW
PARAGRAPH


.
as.
1-(5-fluoropentyl)-
N
-(2-



phenylpropan-2-yl)-1
H
-pyrrolo[2,3-b]pyridine-3-carboxamide.



Other
name:
5F-CUMYL-P7AICA.



NEW
PARAGRAPH


.
at.
Ethyl
2-(1-(5-fluoropentyl)-1H-



indazole-3-carboxamido)-3,3-dimethylbutanoate,
its
optical,



positional,
and
geometric
isomers,
salts
and
salts
of
isomers



(other
name:
5F-EDMB-PINACA).










Senate
File
2119,
p.
6


NEW
PARAGRAPH


.
au.
Methyl
2-(1-(5-fluoropentyl)-1H-indole-



3-carboxamido)-3,3-dimethylbutanoate,
its
optical,
positional,



and
geometric
isomers,
salts
and
salts
of
isomers
(other
name:



5F-MDMB-PICA).



NEW
PARAGRAPH
.
av.
N-(adamantan-1-yl)-1-(4-fluorobenzyl)-



1H-indazole-3-carboxamide,
its
optical,
positional,
and



geometric
isomers,
salts
and
salts
of
isomers
(other
names:



FUB-AKB48,
FUB-APINACA,
AKB48
N-(4-FLUOROBENZYL)).



NEW
PARAGRAPH


.
aw.
1-(5-fluoropentyl)-N-(2-



phenylpropan-2-yl)-1H-indazole-3-carboxamide,
its
optical,



positional,
and
geometric
isomers,
salts
and
salts
of
isomers



(other
names:
5F-CUMYL-PINACA,
SGT-25).



NEW
PARAGRAPH


.
ax.
(1-(4-fluorobenzyl)-1H-



indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)
methanone,
its



optical,
positional,
and
geometric
isomers,
salts
and
salts
of



isomers
(other
name:
FUB-144).



Sec.
8.
Section
124.206,
subsection
7,
paragraph
a,
Code



2020,
is
amended
by
striking
the
paragraph.



Sec.
9.
Section
124.208,
subsection
3,
paragraph
c,
Code



2020,
is
amended
to
read
as
follows:



c.
Any
substance
which
contains
any
quantity
of
a
derivative



of
barbituric
acid
or
any
salt
thereof
including
but
not





limited
to
Fioricet
.



Sec.
10.
Section
124.210,
subsection
3,
Code
2020,
is



amended
by
adding
the
following
new
paragraph:



NEW
PARAGRAPH


.
bd.
Brexanolone.



Sec.
11.
Section
124.210,
subsection
6,
Code
2020,
is



amended
by
adding
the
following
new
paragraph:



NEW
PARAGRAPH


.
m.
Solriamfetol
(2-amino-3-phenylpropyl



carbamate;
benzenepropanol,
beta-amino-,
carbamate
(ester).



Sec.
12.
Section
124.212,
Code
2020,
is
amended
by
adding



the
following
new
subsection:



NEW
SUBSECTION


.
6.
Approved
cannabidiol
drugs.
A



drug
product
in
finished
dosage
formulation
that



has
been
approved
by
the
United
States
food
and



drug
administration
that
contains
cannabidiol



(2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-



pentyl-1,3-benzenediol)
derived
from
cannabis
and
no
more
than



0.1
percent
(w/w)
residual
tetrahydrocannabinols.













Senate
File
2119,
p.
7


Sec.
13.
EFFECTIVE
DATE.
This
Act,
being
deemed
of



immediate
importance,
takes
effect
upon
enactment.



______________________________


CHARLES
SCHNEIDER


President
of
the
Senate


______________________________


PAT
GRASSLEY


Speaker
of
the
House


I
hereby
certify
that
this
bill
originated
in
the
Senate
and


is
known
as
Senate
File
2119,
Eighty-eighth
General
Assembly.


______________________________


W.
CHARLES
SMITHSON


Secretary
of
the
Senate


Approved
_______________,
2020
______________________________


KIM
REYNOLDS


Governor

